LeMaitre Vascular
LMAT
181 hedge funds and large institutions have $845M invested in LeMaitre Vascular in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 64 increasing their positions, 65 reducing their positions, and 22 closing their positions.
2% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 65
3.63% less ownership
Funds ownership: 87.13% → 83.5% (-3.6%)
4% less funds holding
Funds holding: 188 → 181 (-7)
13% less capital invested
Capital invested by funds: $970M → $845M (-$124M)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
+$2.52M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.45M |
| 3 |
MOACM
Mutual of America Capital Management
New York
|
+$2.02M |
| 4 |
ProShare Advisors
Bethesda,
Maryland
|
+$1.67M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$9.07M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$2.56M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.17M |
| 4 |
Goldman Sachs
New York
|
-$1.18M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$1.07M |
LMAT Hedge Fund Activity: Q4 2022 in Review
181 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2022, worth a combined $845M — down 13% from $970M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of LMAT and 18 opened new positions — a net loss of 4 holders — while 65 trimmed existing stakes and 64 added.
The largest buyer was Copeland Capital Management, adding an estimated $2.52M. The largest seller was VOYA Investment Management, cutting an estimated $9.07M.
- 181 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2022, down from 188 in Q3 2022.
- Funds reported $845M of LeMaitre Vascular stock for Q4 2022, down 13% quarter-over-quarter.
- 18 funds opened new LeMaitre Vascular positions in Q4 2022 and 22 closed out, a net change of -4 holders.
- The largest LeMaitre Vascular buyer in Q4 2022 was Copeland Capital Management, an estimated $2.52M added.
- The largest LeMaitre Vascular seller in Q4 2022 was VOYA Investment Management, an estimated $9.07M sold.
Based on aggregated 13F filings for Q4 2022.